Simplex Trading
RPRX

Simplex Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Simplex Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,985
Closed -$2.17K – 7516
2017
Q1 		$3K Buy
2,985
+2,375
+389% +$2.97K ﹤0.01% 5185
2016
Q4 		$0 Sell
610
-73,996
-99% -$129K ﹤0.01% 7297
2016
Q3 		$155K Sell
74,606
-11,448
-13% -$22.6K 0.01% 1216
2016
Q2 		$138K Buy
+86,054
New +$165K 0.01% 1253
2015
Q4 		– Sell
-18,831
Closed -$60.4K – 6999
2015
Q3 		$139K Buy
+18,831
New +$144K 0.01% 1156
2015
Q2 		– Sell
-17,066
Closed -$133K – 6625
2015
Q1 		$146K Sell
17,066
-3,836
-18% -$34.3K 0.02% 871
2014
Q4 		$208K Buy
+20,902
New +$178K 0.03% 586

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's RPRX Position: Q2 2017 in Review

Simplex Trading sold out of Repros Therapeutics Inc. (RPRX) in Q2 2017, closing a stake of 2,985 shares — an estimated $2.17K sold.

Simplex Trading first reported a position in RPRX in Q4 2014 and held it in 7 quarters. The position peaked at $208K in Q4 2014. 29 funds tracked by Wall St. Rank hold RPRX as of Q2 2017.

  • Simplex Trading reported no remaining Repros Therapeutics Inc. position as of Q2 2017 after selling out during the quarter.
  • Simplex Trading sold 2,985 Repros Therapeutics Inc. shares in Q2 2017, an estimated $2.17K.
  • Simplex Trading first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 7 quarters.
  • Simplex Trading's Repros Therapeutics Inc. position peaked at $208K in Q4 2014.
  • 29 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2017.

Based on Simplex Trading's 13F filing for Q2 2017, filed 12 Jul 2017.